{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:39:20Z","timestamp":1785332360907,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Neuroscience Research Group of the Hungarian Academy of Sciences"},{"name":"University of Szeged"},{"name":"FNUSA-ICRC","award":["CZ.1.05\/1.1.00\/02.0123"],"award-info":[{"award-number":["CZ.1.05\/1.1.00\/02.0123"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Brain Research Program","award":["KTIA_13_NAP-A-II\/20"],"award-info":[{"award-number":["KTIA_13_NAP-A-II\/20"]}]},{"DOI":"10.13039\/501100003549","name":"OTKA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jocn.2017.10.030","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T12:02:49Z","timestamp":1510315369000},"page":"7-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Paraneoplastic neuromyelitis optica spectrum disorder: A case report and review of the literature"],"prefix":"10.1016","volume":"48","author":[{"given":"\u00c1d\u00e1m","family":"Annus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Bencsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella","family":"Ob\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsigmond Tam\u00e1s","family":"Kincses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Tiszlavicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2017.10.030_b0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2017.10.030_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00296-014-3066-3","article-title":"Neuromyelitis optica spectrum disorders associated with other autoimmune diseases","volume":"35","author":"Freitas","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jocn.2017.10.030_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2015.05.034","article-title":"Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: a review","volume":"355","author":"Pereira","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2017.10.030_b0020","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2017.10.030_b0025","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archneur.65.5.629","article-title":"Aquaporin-4 autoantibodies in a paraneoplastic context","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2017.10.030_b0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2010.07.016","article-title":"Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis","volume":"227","author":"Chan","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2017.10.030_b0035","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy","volume":"63","author":"Kister","year":"2006","journal-title":"Arch Neurol"},{"issue":"39","key":"10.1016\/j.jocn.2017.10.030_b0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mus.21197","article-title":"Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica","author":"McKeon","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2017.10.030_b0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1179\/2045772312Y.0000000018","article-title":"Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment","volume":"35","author":"Arma\u011fan","year":"2012","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.jocn.2017.10.030_b0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2407-11-161","article-title":"Loss of aquaporin-4 expression and putative function in non-small cell lung cancer","volume":"11","author":"Warth","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jocn.2017.10.030_b0055","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/jnr.21224","article-title":"Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival","volume":"85","author":"Warth","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jocn.2017.10.030_b0060","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/WNL.0b013e318211c379","article-title":"CSF complements serum for evaluating paraneoplastic antibodies and NMO-IgG","volume":"76","author":"McKeon","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2017.10.030_b0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","article-title":"Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature","volume":"114","author":"Jarius","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jocn.2017.10.030_b0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2017.10.030_b0075","first-page":"660","article-title":"Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature","volume":"126","author":"Cai","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jocn.2017.10.030_b0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2017.10.030_b0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp.2006.097972","article-title":"Devic's syndrome-like phenotype associated with thymoma and anti-CV2\/CRMP5 antibodies","volume":"78","author":"Ducray","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2017.10.030_b0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-065X.2012.01144.x","article-title":"Neural antigen-specific autoimmune disorders","volume":"248","author":"Iorio","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jocn.2017.10.030_b0095","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2017.10.030_b0100","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2017.10.030_b0105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.biocel.2012.06.013","article-title":"Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies","volume":"44","author":"Ratelade","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jocn.2017.10.030_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2169\/internalmedicine.51.5636","article-title":"Elderly-onset neuromyelitis optica which developed after the diagnosis of prostate adenocarcinoma and relapsed after a 23-valent pneumococcal polysaccharide vaccination","volume":"51","author":"Kitazawa","year":"2012","journal-title":"Int Med"},{"issue":"66","key":"10.1016\/j.jocn.2017.10.030_b0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","author":"Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2017.10.030_b0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"Saadoun","year":"2010","journal-title":"Brain"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817310755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586817310755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T00:24:25Z","timestamp":1535243065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586817310755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":24,"alternative-id":["S0967586817310755"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.10.030","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paraneoplastic neuromyelitis optica spectrum disorder: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}